Eugene Yuk-Keung Tso

Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial

Ivan Fan-Ngai Hung, Kwok-Cheung Lung, Eugene Yuk-Keung Tso et al. · The Lancet · 2020 · 1.6K citations · Full text

Triple Combination, Covid-19 Pandemic, Antiviral Drug Development +7

Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome Sequencing

Kelvin Kai‐Wang To, Ivan Fan‐Ngai Hung, Jonathan Daniel Ip et al. · Clinical Infectious Diseases · 2020 · 815 citations · Full text

Coronavirus-positive Nasopharyngeal Aspirate as Predictor for Severe Acute Respiratory Syndrome Mortality

Owen Tak-Yin Tsang, Tai‐Nin Chau, Kin‐Wing Choi et al. · Emerging infectious diseases · 2003 · 99 citations · Full text

Detection of SARS-CoV-2 in conjunctival secretions from patients without ocular symptoms

Xin Li, Jasper Fuk‐Woo Chan, Kenneth Kai-Wang Li et al. · Infection · 2020 · 50 citations · Full text

Ocular Disease, Ophthalmology, Virology +5

Bacterial co-infections and antibiotic prescribing practice in adults with COVID-19: experience from a single hospital cluster

Lily S. Cheng, Sandy Ka-Yee Chau, Eugene Yuk-Keung Tso et al. · Therapeutic Advances in Infectious Disease · 2020 · 46 citations · Full text